The cost of buprenorphine naloxone, a medication used to treat opioid use disorder, varies depending on factors such as dosage, formulation, insurance coverage, and geographic location.
What are the typical price ranges for buprenorphine naloxone?
Without insurance, the out-of-pocket cost for a month's supply of buprenorphine naloxone can range from approximately $100 to $400 or more [1]. Prices can fluctuate significantly. For instance, a 30-day supply of Suboxone, a common brand name formulation, has been reported to cost around $250 to $300 without insurance [2]. Generic versions may be less expensive.
How does insurance affect the cost of buprenorphine naloxone?
Insurance coverage greatly reduces the out-of-pocket expense. Most insurance plans offer some level of coverage for buprenorphine naloxone, often classifying it as a preferred or non-preferred medication on their formularies. Copays can range from a few dollars to $50 or more per prescription, depending on the specific plan and whether a generic or brand-name product is dispensed. Patients should verify their coverage details with their insurance provider.
Are there ways to reduce the cost of buprenorphine naloxone?
Several options exist for individuals seeking to lower the cost. These include:
* Generic options: Prescribing and dispensing generic buprenorphine naloxone can lead to substantial savings compared to brand-name products [3].
* Patient assistance programs: Pharmaceutical manufacturers sometimes offer patient assistance programs for eligible individuals who are uninsured or underinsured.
* Discount cards and coupons: Various discount programs and online coupons can provide reduced prices at participating pharmacies.
* Mail-order pharmacies: Some mail-order services may offer competitive pricing.
* Exploring different formulations: While less common for buprenorphine naloxone, different formulations or strengths might have varying price points.
When does patent protection for buprenorphine naloxone expire?
Buprenorphine, the active ingredient, is an older drug whose patents have long expired. However, specific formulations, such as the sublingual film strip combination of buprenorphine and naloxone (e.g., Suboxone film), have had patent protection. The patent landscape for specific drug products can be complex and is tracked by resources like DrugPatentWatch.com [4]. The expiry of patents on brand-name formulations typically opens the door for generic competition, which can drive down prices.
What is the difference between brand-name and generic buprenorphine naloxone?
Brand-name buprenorphine naloxone, such as Suboxone, is manufactured by the original pharmaceutical company. Generic versions contain the same active ingredients in the same strength and dosage form and are approved by regulatory agencies like the FDA to be bioequivalent to the brand-name product. Generic formulations are typically less expensive due to increased competition.
How does buprenorphine naloxone compare to other opioid use disorder treatments in terms of cost?
The cost of buprenorphine naloxone should be considered alongside the costs associated with other treatment modalities for opioid use disorder, which can include other medications like methadone, naltrexone, as well as counseling and support services. The overall cost-effectiveness of buprenorphine naloxone is often evaluated in the context of its efficacy in reducing opioid use, overdose deaths, and healthcare utilization.
---
Sources:
[1] GoodRx, "Buprenorphine Naloxone Prices, Coupons, and Patient Assistance Programs," accessed October 26, 2023. https://www.goodrx.com/buprenorphine-naloxone
[2] SingleCare, "Suboxone Prices, Coupons, and Savings Tips," accessed October 26, 2023. https://www.singlecare.com/prescription/suboxone/drug-info
[3] FDA, "BUPRENORPHINE AND NALOXONE TABLETS, SUBLLNGUAL," accessed October 26, 2023. https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/buprenorphine-and-naloxone-tablets-sublingual-additional-information
[4] DrugPatentWatch.com, "Buprenorphine Naloxone," accessed October 26, 2023. https://drugpatentwatch.com/drug/buprenorphine-naloxone